Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease

World Journal of Gastroenterology

Volumn 9, Issue 12, 2003, Pages 2801-2804

  Kanazawa, Yusei ^a   Isomoto, Hajime ^a   Wen, Chun Yang ^a   Wang, Ai Ping ^a   Saenko, Vladimir A ^a   Ohtsuru, Akira ^a   Takeshima, Fuminao ^a   Omagari, Katsuhisa ^a   Mizuta, Yohei ^a   Murata, Ikuo ^b   Yamashita, Shunichi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; MESSENGER RNA; PRIMER DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLASSIFICATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DRINKING BEHAVIOR; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATION; LOWER ESOPHAGUS SPHINCTER; MALE; NON EROSIVE REFLUX DISEASE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SMOKING; VIRUS DETECTION;

EID: 9144257559     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i12.2801     Document Type: Article

References (22)

1. Fass R, Ofman JJ. Gastroesophageal reflux disease - Should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97: 1901-1909
2. Frierson HF Jr. Histology in the diagnosis of reflux esophagitis. Gastroenterol Clin N Am 1990; 19: 631-644
3. Quigley EMM. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98(Suppl): S24-S30
4. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. The endoscopic assessment of oesophagitis: A progress report on observer agreement. Gastroenterology 1996; 111: 85-92
5. Hoshihara Y, Hashimoto M. Endoscopic classification of reflux esophagitis. Nippon Rinsho 2000; 58: 1808-1812
6. Nishiyama Y, Koyama S, Andoh A, Moritani S, Kushima R, Fujiyama Y, Hattori T, Bamba T. Immunohistochemical analysis of cell cycle-regulating-protein (p21, p27, and Ki-67) expression in gastroesophageal reflux disease. J Gastroenterol 2002; 37: 905-911
7. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: Immunological determinants. Gut 2002; 50: 451-459
8. Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase K, Hayashi T, Inoue K, Murata I, Kohno S. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003; 98: 551-556
9. Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, Farthing MJ. Inflammatory gradient in Barrett's oesophagus: Implications for disease complications. Gut 2002; 51: 316-322
10. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023-1029
11. Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 1711-1717
12. Yuan A, Yang PC, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 2000; 162: 1957-1963
13. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, Abrosimov AY, Lushnikov EF, Roumiantsev PO, Ohtsuru A, Namba H, Tsyb AF, Yamashita S. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res 2002; 62: 7031-7041
14. Kondo S, Yoneta A, Yazawa H, Kamada A, Jimbow K. Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. J Cell Physiol 2000; 182: 366-370
15. Ohnita K, Isomoto H, Mizuta Y, Maeda T, Haraguchi M, Miyazaki M, Murase K, Murata I, Tomonaga M, Kohno S. Helicobacter pylori infection in patients with gastric involvement by adult T-cell leukemia/lymphoma. Cancer 2002; 94: 1507-1516
16. Isomoto H, Furusu H, Morikawa T, Mizuta Y, Nishiyama T, Omagari K, Murase K, Inoue K, Murata I, Kohno S. 5-Day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 1619-1623
17. Mukaida N. Interleukin-8: An expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72: 391-398
18. Graca-Souza AV, Arruda MA, De Freitas MS, Barja-Fidalgo C, Oliveira PL. Neutrophil activation by heme: Implications for inflammatory processes. Blood 2002; 99: 4160-4165
19. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: Possible functions of each receptor. J Immunol 1995; 155: 2587-2594
20. Metzner B, Hofmann C, Heinemann C, Zimpfer U, Schraufstatter I, Schopf E, Norgauer J. Overexpression of CXC-chemokines and CXC-chemokine receptor type 2 constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431. Oncol Rep 1996; 6: 1405-1410
21. Zachrisson K, Neopikhanov V, Samali A, Uribe A. Interleukin-1, interleukin-8, tumour necrosis factor alpha and interferon gamma stimulate DNA synthesis but have no effect on apoptosis in small intestinal cell lines. Eur J Gastroenterol Hepatol 2001; 13: 551-559
22. Sfakianakis A, Barr CE, Kreutzer DL. Localization of the chemokine interleukin-8 receptors in human gingival and cultured gingival keratinocytes. J Periodont Res 2002; 87: 154-160